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Abstract
Introduction: A nationwide multicentre study was conducted to establish well-defined reference intervals (RIs) of haematological parameters for 
the Turkish population in consideration of sources of variation in reference values (RVs).
Materials and methods: K2-EDTA whole blood samples (total of 3363) were collected from 12 laboratories. Sera were also collected for measure-
ments of iron, UIBC, TIBC, and ferritin for use in the latent abnormal values exclusion (LAVE) method. The blood samples were analysed within 2 
hours in each laboratory using Cell Dyn and Ruby (Abbott), LH780 (Beckman Coulter), or XT-2000i (Sysmex). A panel of freshly prepared blood from 
40 healthy volunteers was measured in common to assess any analyser-dependent bias in the measurements. The SD ratio (SDR) based on ANOVA 
was used to judge the need for partitioning RVs. RIs were computed by the parametric method with/without applying the LAVE method.
Results: Analyser-dependent bias was found for basophils (Bas), MCHC, RDW and MPV from the panel test results and thus those RIs were derived 
for each manufacturer. RIs were determined from all volunteers’ results for WBC, neutrophils, lymphocytes, monocytes, eosinophils, MCV, MCH and 
platelets. Gender-specific RIs were required for RBC, haemoglobin, haematocrit, iron, UIBC and ferritin. Region-specific RIs were required for RBC, 
haemoglobin, haematocrit, UIBC, and TIBC. 
Conclusions: With the novel use of a freshly prepared blood panel, manufacturer-specific RIs’ were derived for Bas, Bas%, MCHC, RDW and MPV. 
Regional differences in RIs were observed among the 7 regions of Turkey, which may be attributed to nutritional or environmental factors, including 
altitude. 
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Introduction
In recent years, the Committee on Reference Inter-
vals and Decision Limits (C-RIDL) of the Interna-
tional Federation of Clinical Chemistry and Labo-
ratory Medicine (IFCC) proposed a country-wide 
multicentre study for the derivation of reference 
intervals (RIs) in a harmonized way by recruiting a 
sufficient number of reference individuals togeth-
er with the use of an issued protocol and standard 
operating procedures (SOPs) (1,2). The protocol 
recommends centralized measurements to avoid 
assay platform dependent differences in test re-
sults. For international comparison, the use of a 
panel of sera is set as the key strategy for aligning 
test results among laboratories (3). The global RIs 
project initiated by C-RIDL involving many coun-
tries, including Turkey, aimed to promote harmo-
nized derivation of reliable country-specific RIs 
through multicentre studies and to compare refer-
ence values (RVs) among the countries using these 
strategies (4). We joined the global project and 
conducted a nationwide multicentre study to es-
tablish RIs of the Turkish population for biochemi-
cal parameters and to explore sources of variation 
in RVs, including regionality (5). 
After establishing the RIs for biochemical analytes, 
another multicentre study was initiated to estab-
lish RIs for haematological parameters. Haemato-
logical parameters, especially the complete blood 
count (CBC), are the most commonly measured 
tests in clinical laboratories and it is well known 
that the RIs of haematological parameters vary 
with age and gender and require population-spe-
cific RIs (6). According to the European Directive 
98/79 on in vitro diagnostic medical devices, diag-
nostic kit manufacturers are obliged to supply 
their clients with appropriate reference RIs for use 
with their assay platforms and reagents. Further-
more, the International Organization for Standard-
ization Standard 15189 for clinical laboratory ac-
creditation states that each laboratory should pe-
riodically re-evaluate its own RIs (7,8). However, 
despite these facts and requirements, attempts to 
establish specific RIs for haematology parameters 
are still uncommon and are applied to insufficient 
sample sizes. There have been a limited number of 
attempts (6,9,10) to conduct appropriate multicen-
tre studies to achieve this goal, because with the 
exception of the concentration of haemoglobin, 
there are no standard reference materials; native 
samples must be measured fresh and cannot be 
measured or re-analysed after storage (9).
Turkey consists of 7 geographical regions, which 
extend more than 1600 km from the Aegean Sea 
in the west to the Iranian border in the east. Turkey 
encompasses an area of 780,580 km2 with a popu-
lation of approximately 80 million (11). There are 
large differences in altitude among the regions, 
and altitude is well known to have a significant ef-
fect on CBC parameters (12). These facts aroused 
our interest in investigating the RIs of haematolog-
ical parameters nationwide among the 7 regions 
of Turkey. The study aimed to 1) establish well-de-
fined RIs of haematological parameters for nation-
wide use with high precision from a large number 
of healthy volunteers, 2) evaluate the utility of la-
tent abnormal values exclusion (LAVE) methods 
for reducing the influence of latent anaemia, 3) ex-
plore possible regional differences in the RVs 
among the 7 regions, and 4) investigate analyser 
dependent bias in test results by a novel scheme 
of preparation and common measurement of a 
panel of fresh blood. 
Materials and methods 
Subjects
The study was conducted from January 2015 to 
December 2015. With a recruitment quota of ≥ 400 
volunteers per geographical region, a total of 3363 
healthy individuals participated in the study; as-
says were performed by 12 laboratories from the 7 
geographical regions of Turkey. Healthy individu-
als were selected in accordance with the EP28-A3C 
guideline (13). The target age range was 18 to 79 
years. A questionnaire regarding general health 
and lifestyle was used for the selection of refer-
ence individuals. The essential items required for 
the comparison of the centres are body mass in-
dex (BMI), special diet, records of medicines and/or 
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supplements regularly taken, habits of smoking, 
alcohol consumption per week (roughly expressed 
grams of ethanol), and frequency and strength of 
physical exercise. Exclusion criteria were applied at 
the time of recruitment according to the IFCC/C-
RIDL protocol (2). The volunteers gave written in-
formed consent to participate in the study, and 
they were informed of the results on request. The 
study protocol, the contents of the informed con-
sent form, and the general health and lifestyle 
questionnaire were approved by the Ethics Com-
mittee of Uludag University School of Medicine.
Methods
The procedures for blood collection were per-
formed according to the IFCC/C-RIDL protocol (2). 
The time of the sampling was set at 7−10 am after 
overnight fasting. For harmonization, the same 
blood collection tubes made by Becton Dickinson 
(BD Diagnostics, Oxford, England) were used in all 
laboratories. For CBC, 2 mL of venous blood was 
drawn into a vacuum tube containing potassium 2 
ethylene-diamine-tetraacetic acid (K2 EDTA). For 
iron (Fe), total and unsaturated iron binding capac-
ity (TIBC and UIBC), and ferritin, 5 mL of blood was 
drawn into a vacuum tube with gel serum separa-
tor (SST II) tubes. The sera samples were left thirty 
to sixty minutes to clot formation prior centrifuga-
tion at 1200g for 10 minutes at room temperature 
and the sera were stored at – 80 ± 2 oC for up to 6 
months until analysis.
Haematological analyses were performed for 20 
CBC parameters: white blood cell count (WBC), 
neutrophil absolute count (Neu), neutrophil per-
centage (Neu%), lymphocyte absolute count 
(Lym), lymphocyte percentage (Lym%), monocyte 
absolute count (Mon), monocyte percentage 
(Mon%), basophil absolute count (Bas), basophil 
percentage (Bas%), eosinophil absolute count 
(Eos), eosinophil percentage (Eos%), red blood cell 
count (RBC), haemoglobin (Hb), haematocrit (Hct), 
mean corpuscular volume (MCV), mean corpuscu-
lar haemoglobin (MCH), mean corpuscular haemo-
globin concentration (MCHC), red cell distribution 
width (RDW), platelet count (PLT) and mean plate-
let volume (MPV). The EDTA blood samples were 
analysed within 2 hours in each of the 12 partici-
pating laboratories using 4 different analysers 
from 3 manufacturers: Cell Dyn 3700 and Ruby “A” 
(Abbott Diagnostics, IL, USA); LH780 “BC” (Beck-
man Coulter Diagnostics, CA, USA), and Sysmex 
XT-2000i “S” (Sysmex Corporation, Kobe, Japan). 
Fe, UIBC and TIBC were analysed in each serum 
sample using 10 different analysers made by 4 
manufacturers as shown in Table 1. 
Panels of whole blood and sera
As a key scheme of confirming comparability of 
test results among the collaborating laboratories, 
two panels of specimens were produced in a labo-
ratory in Istanbul. One was a panel of whole 
bloods, and the other was a panel of sera. For the 
first panel, 21 mL of venous blood was taken into 3 
K2EDTA tubes (7.0 mL draw volume) and for the 
second panel, 24 mL of blood was collected into 
gel 3 SST II tubes (8.5 mL draw volume) from each 
volunteer. The blood collection tubes made by BD 
(BD Diagnostics, Oxford, England) were used for 
the preparation of the both panels. Both included 
specimens freshly prepared from 40 healthy vol-
unteers, but from different individuals for each 
panel. A total of 12 sets of the blood panels were 
produced by aliquoting 1.5 mL of blood from each 
individual into Eppendorf tubes immediately after 
drawing blood. Similarly, a total of 12 sets of the 
serum panels were produced by aliquoting 1 mL 
of serum from each individual into Eppendorf 
tubes after serum separation. Both blood and se-
rum panels were placed into polystyrene boxes 
packed with ice bars to keep the temperature be-
tween 10–20 °C and were then distributed to each 
laboratory by airplane or by car within 12 hours af-
ter production then measured after the delivery 
on the same day and at the same time of day in 
each participating laboratory. 
Quality control
Internal and external quality controls (QC) were 
performed in the participating laboratories to 
monitor the stability of the assay. The two levels of 
internal QC materials (low and high control) used 
for analytical coefficients of variation determina-
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Table 1. Analytical systems used for the measurements together with CVA data
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tion were supplied by A (Abbott Diagnostics, IL, 
USA) for A users, BC (Beckman Coulter Diagnostics, 
CA, USA) for BC users, and S (Sysmex Corporation, 
Kobe, Japan) for S users. Randox International 
Quality Assessment Scheme (RIQAS) Haematology 
External Quality Assessment (EQA) Programme 
was used in all the participating laboratories. The 
analytical coefficient of variation (CVA) was com-
puted for each analyte from the results of repeat-
ed measurements of the internal quality control 
material measured in each laboratory. The desira-
ble limits for between-day and within-day CVAs 
were set as a half of the within-individual CV (CVI) 
reported on the Westgard website (14). The with-
in- and between-day CVAs for all analytes, listed in 
Table 1, did not exceed the desirable limits. 
Statistical analysis
In order to evaluate the magnitude of between-
laboratory bias in test results of the blood/serum 
panel or those of volunteers’ samples, the stand-
ard deviation (SD) representing between-labora-
tory variation (SDBL) was computed based on one-
way ANOVA. The relative magnitude of SDBL to 
that of residual SD (or net between-individual SD: 
SDBI) was computed as the SD ratio (SDR): SDRBL = 
SDBL / SDBI. For detailed analysis of sources of vari-
ation of RVs, SDRs for between-gender (SDRgender), 
between-age subgroup differences (SDRage) and 
between-region (SDRBR), were computed based 
on 3-level nested ANOVA (15). In the analysis of 
Eos, Eos%, Bas, Bas%, and ferritin, test results were 
transformed logarithmically because of their 
skewed distribution patterns. For those parame-
ters, any subset of SD derived in the logarithmic 
scale (SDT) was back-transformed (16).
Multiple regression analysis (MRA) was performed 
to identify factors possibly associated with the test 
results, including age, BMI, altitude of the regions 
above sea level, and level of cigarette smoking, al-
cohol drinking and physical exercise. In the analy-
sis, dummy variables representing the Turkish re-
gions, with Marmara set as the reference region, 
were also introduced to adjust for any possible in-
fluence of place of residence on RVs. 
Judgment of analytical bias among the 
laboratories from the panel test results
Between-laboratory SDR computed from the pan-
el test results (SDRBL1) was used to assess the ana-
lyser dependent bias in test results among the lab-
oratories. We adopted SDR > 0.30 as a guide value 
for judging the analytical bias among the labora-
tories. If there was only one laboratory showing an 
obvious bias, we excluded the panel test results 
from that laboratory and recomputed the SDRBL1. 
If SDRBL1 remained > 0.30, we then checked for the 
consistency of the findings in volunteers’ test re-
sults (SDRBL2) as described below before deciding 
on the need for haematology analyser specific 
analysis of RVs.
The criterion for partitioning reference values 
and derivation of reference intervals 
In the absence of bias in the panel test results 
(SDRBL1 ≤ 0.3), SDRBL2 of > 0.3 was regarded as a re-
gional difference requiring partition for the deriva-
tion of RIs. For the parameters found to have large 
between-manufacturer differences (SDRBM > 0.3) 
in the panel test results, we partitioned the RVs by 
manufacturer. 
The lower and upper limits (LL and UL) of the RIs 
were derived by the parametric method after nor-
malizing the data distribution using the modified 
Box-Cox power transformation method (15). The 
90% confidence intervals (CIs) for LL and UL were 
estimated by use of the bootstrap method 
through iterative resampling 100 times. Using this 
procedure, the final LL and UL were set as the av-
erage after 100 iterations.
As a method for secondary exclusion of RVs to 
cope with a high prevalence of latent anaemia, the 
LAVE method was applied by allowing one abnor-
mal result in 7 reference test items (Hb, Hct, MCV, 
Fe, UIBC, TIBC, and ferritin) which reflect anaemic 
disorders (15-17). Thus, the RIs were derived in two 
ways, either with or without the LAVE method. The 
choice between the two RIs was made by the ratio 
of the difference in the two LLs (or ULs) to the SD 
comprising the RI, which corresponds to between-
individual SD (SDBI), as follows (17): 
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77 
  355
Ozarda Y. et al. Reference intervals of haematology parameters in Turkey
ΔLL ratio = | LL– – LL+ | / (UL+ – LL+) / 3.92
ΔUL ratio = | UL– – UL+ | / (UL+ – LL+) / 3.92
where LL+, LL– ( or UL+, UL– ) represent LL (or UL) de-
termined with/without the LAVE method, respec-
tively. We set the critical value for ΔLL (or ΔUL) ra-
tio as 0.25 in analogy to the theory of acceptable 
analytical bias in laboratory tests since the numer-
ator of ΔLL (or ΔUL) ratio is a bias by the choice of 
derivation method and the denominator corre-
sponds to SDBI (14).
Results
Analytical bias in test results among the 
laboratories
The age and gender distributions of the partici-
pants from the 7 regions of Turkey are shown in 
Table 2. The male to female ratio was close to 1.0. 
The majority of participants (2914; 86.6% of the to-
tal) were between 20 and 59 years old (Table 2). 
To see any analyser dependent bias in the meas-
urements among the 12 laboratories, the be-
tween-laboratory SDR for the panel test results 
(SDRBL1) was computed as shown in Column 2 of 
Table 3. SDRBL1 > 0.3 was noted for 10 parameters 
(Neu, Neu%, Mon, Mon%, Bas, Bas%, MCV, MCHC, 
RDW, and MPV). The implication of the bias was 
then evaluated in reference to the actual distribu-
tions of the panel test results among the 12 labo-
ratories as shown in Figure 1.
For Neu and Neu%, an obvious bias in measure-
ments from Urfa was identified in Figure 1- {2,3} 
due to an unknown technical problem. However, 
removal of the results led to a reduction in SDRBL1 
from 0.48 to 0.26 for Neu, and from 0.60 to 0.00 for 
Neu%. On the other hand, the between-laborato-
ry SDRs for Neu and Neu% based on volunteers’ 
test results (SDRBL2) shown in Column 6 of Table 3 
were 0.20 and 0.15, respectively. Therefore, we 
judged that neither analyser dependent bias nor 
regional difference existed for Neu and Neu%, and 
thus all the results from the 12 laboratories could 
be combined to derive the RIs.
For MCV, we observed in Figure 1 - {15} that there 
was a similar problem of bias in the measurements 
from Mersin and again removal of the results led 
Gender, N Region 18-29 y 30-39 y 40-49 y 50-59 y 60-69 y 70-79 y Total (N)
Male, 1614
Aegean 46 36 37 49 15 6 189
Black Sea 63 75 73 56 31 1 299
Central Anatolia 63 89 55 38 38 7 290
Eastern Anatolia 63 61 47 25 20 7 223
Marmara 35 52 48 21 6 11 173
Mediterranean 40 36 32 37 20 21 186
Southeastern Anatolia 58 57 61 43 26 9 254
Female, 1746
Aegean 42 64 41 48 35 3 233
Black Sea 61 77 65 44 26 1 274
Central Anatolia 76 73 68 59 34 11 321
Eastern Anatolia 72 60 55 32 14 9 242
Marmara 55 74 67 25 11 1 233
Mediterranean 42 45 41 44 20 28 220
Southeastern Anatolia 48 37 48 53 38 2 226
Total (N) 764 836 738 574 334 117 3363
y – years old.
Table 2. Age and gender of the volunteers from the 7 regions of Turkey
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Figure 1. Between-laboratory comparison of test results for the blood/serum panel and volunteers’ samples
For all 12 laboratories, the distributions of test results for all haematological parameters were drawn for the blood/serum panels (left 
graphs) and for volunteers’ test results of males and females (middle and right graphs). The 12 laboratories are placed in the order of 
the manufacturers (A: Abbott; BC: Beckman Coulter; S: Sysmex), for WBC, Neu, Neu%, Lym, Lym%, Mon, Mon%, Eos, Eos%, Bas, Bas%, 
MCV, MCH, MCHC, RDW, PLT and MPW but, for RBC, Hb, Hct, Fe, Ferritin, UIBC and TIBC due to our judgement of regional differences, 
the laboratories are aligned in the order of geographical regions (1: Marmara, 2: Aegean, 3: Mediterranean, 4: Black Sea, 5: Central 
Anatolia, 6: East Anatolia, 7: South East Anatolia).  
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* between-lab SDR after limiting labs using BC and Sy analyzer
Panel Male FemaleSDR BL2 =0.69⇒0.32* SDR BL2=0.39⇒0.29*SDR BL1 =1.28⇒0.00*
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to a reduction in SDRBL1 from 0.44 to 0.15. After re-
moval of the biased test results, SDRBL2 reduced 
below 0.3 as shown in Column 6 of Table 3, and 
thus we chose to combine all the results for deriva-
tion of the RI for MCV.
For Mon and Mon%, we observed apparent be-
tween-laboratory differences in the panel test re-
sults (SDRBL1 of 0.54 and 0.62, respectively) with a 
tendency of analyser dependent bias. However, 
SDRBL2 based on volunteers’ results were < 0.3 for 
males and females as shown in Figure 1 - {6,7} and 
Column 6 of Table 3. Thus, we assumed that mono-
cytes in the blood panel, which were measured 13 
hours after preparation, were not stable during 
transportation at 10 – 20 °C. Therefore, we ignored 
the panel test results and decided to combine the 
results for Mon and Mon% from all the laborato-
ries to derive the RIs.
For Bas and Bas%, a large between-laboratory dif-
ference was observed in the panel test results 
(SDRBL1 of 1.08 and 1.15, respectively) and in the 
volunteers’ test results (SDRBL2 of 0.61 and 0.62, re-
spectively). This indicated the analyser dependen-
cy of Bas and %Bas measurements as shown in 
Figure 1 - {10,11}. By grouping the haematology an-
alysers used in the 12 laboratories under the head-
ings of the 3 manufacturers, the between-manu-
facturer SDR (SDRBM) of Bas and Bas% were com-
{23}
{24}
Figure 1 (continued). Between-laboratory differences computed as SD ratio (SDR) were denoted as SDRBL1 for the panel test results 
and as SDRBL2 for volunteers’ test results. SDR > 0.30 was used as a guide value for judging the presence of analytical bias or regional 
difference among the laboratories. The laboratories which showed a prominent bias were indicated with a circle around the name. 
In special situations where a laboratory showed obvious bias, analyser dependency, or regionality of test results, the SDR was recom-
puted after excluding Urfa for Neu and Neu%, after excluding Mersin for MCV, after regrouping test results by manufacturers for Bas, 
Bas%, and MPV, after regrouping laboratories by region for RBC, Hb, Hct, UIBC and TIBC, after limiting results to laboratories using BC 
and S analysers for RDW, after limiting test results to laboratories using BC analysers for MCHC, and after excluding results from Izmir 
for ferritin.
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(M, F) SDRBR SDRBM Scheme for deriving RIsAll centres Aft excl
WBC 0.24 - 0.11 0.00(0.00, 0.00 )
0.25
(0.27, 0.23) - - RI from all labs’ results
Neu 0 .48 0.26* 0.00 0.05(0.03, 0.07 )
0.20
(0.22, 0.18) - - RI from all labs’ results
%Neu 0 .60 0.00* 0.10 0.10(0.10, 0.10 )
0.15
(0.18, 0.10) - - RI from all labs’ results
Lym 0.18 - 0.10 0.07(0.10, 0.00 )
0.18
(0.18, 0.19) - - RI from all labs’ results
%Lym 0.06 - 0.00 0.14(0.15, 0.12 )
0.07
(0.11, 0.00) - - RI from all labs’ results
Mon 0 .54 - 0.31 0.14(0.16, 0.02 )
0.12
(0.29, 0.20) - - RI from all labs’ results
%Mon 0 .62 - 0.23 0.07(0.12, 0.00 )
0.07
(0.12, 0.00) - - RI from all labs’ results
Eos 0.00 - 0.25 0.03(0.02, 0.04 )
0.15
(0.19, 0.10) - - RI from all labs’ results
%Eos 0.00 - 0.23 0.05(0.00, 0.07 )
0.16
(0.18, 0.15) - - RI from all labs’ results
Bas 1 .08 - 0.04 0.17(0.13, 0.18 )
0 .61
(0 .67, 0 .55) -
0 .71
(0 .79, 0 .65) RIs for 3 manufacturers
%Bas 1 .15 - 0.00 0.00(0.10, 0.23 )
0 .62
(0 .68, 0 .57) -
0 .76
(0 .83, 0 .70) RIs for 3 manufacturers
RBC 0.26 - 1 .00 0.16(0.24, 0.00 )
0 .49
(0 .54, 0 .40)
0 .45
(0 .50, 0 .38) -
RIs for 7 regions for each 
sex
Hb 0.11 - 1 .26 0.19(0.28, 0.00 )
0 .41
(0 .47, 0 .35)
0 .39
(0 .44, 0 .34) -
RIs for 7 regions for each 
sex
Hct 0.30 - 1 .20 0.11(0.17, 0.00 )
0 .53
(0 .59, 0 .48)
0 .50
(0 .54, 0 .45) -
RIs for 7 regions for each 
sex
MCV 0 .44 0.15† 0.17 0.07(0.11, 0.03 )
0 .33
(0 .36, 0 .31)
0.25
(0.22, 0.27)†
- - RI from all labs’ results
MCH 0.29 - 0.27 0.00(0.00, 0.00 )
0 .30
(0.29, 0 .33) - - RI from all labs’ results
MCHC 1 .00 0.08§ 0.27 0.00(0.00, 0.00 )
0 .66
(0 .68, 0 .65)
0.36
(0 .44, 0.31)§
- - RI for BC
RDW 1 .28 0.00|| 0.21 0.13(0.30, 0.00 )
0 .50
(0 .69, 0 .39) 
0.30
(0.32, 0.29)||
- - RI for BC + Sy
PLT 0.23 - 0.23 0.10(0.08, 0.11 )
0.24
(0.28, 0.20) - - RI from all labs’ results
Table 3. Analyses of between-laboratory differences in test results of the blood/serum panel and volunteers’ specimens to assess 
the need for partitioning reference values
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MPV 0 .75 - 0.00 0.00(0.00, 0.00 )
0 .68
(0 .68, 0 .69) -
0 .67 (0 .60, 
0 .68) RIs for 3 manufacturers
Fe 0.00 - 0 .40 0.11(0.16, 0.00 )
0.17
(0.17, 0.16) - -
RIs from all labs’ results for 
each sex
UIBC 0.25 - 0 .43 0.00(0.09, 0.00 )
0 .44 
(0 .42, 0 .46)
0 .37 (0 .34, 
0 .40 ) -
RIs for 7 regions for each 
sex
TIBC 0.28 - 0.29 0.00(0.00, 0.00 )
0 .55 
(0 .49, 0 .59)
0 .46 (0 .38, 
0 .52 ) - RIs for 7 regions
Ferritin 0.12 - 0 .84 0 .35 (0.00, 0 .49 )




- - RIs from all labs’ results for each sex
SDR - standard deviation ratio, the ratio of the standard deviation for a given factor to that for a net between-individual variation. 
By use of 3-level nested ANOVA, the magnitudes (SD) of between-sex, -age, -region variation were computed relative to the net 
between-individual SD as SDR. SDR-sex, SDR-age, and SDR-region denote SDR for between-sex, between-age, and between-region 
differences, respectively. The SDRs in parentheses represent those computed after partitioning data to males (M) and females (F) 
by use of 2-level nested ANOVA, setting age and birth place (or region) as the target factors. The bold characters indicate SDR > 0.3. 
SDRBL1 - between laboratory SDR based on panel test results. Aft excl - after exclusion. SDRBL2 - between laboratory SDR based on 
volunteers’ test results. SDRBR - between region SDR. SDRBM - between manufacturer SDR. RIs - reference Intervals. BC – Beckmann 
Coulter. Sy – Sysmex.
*after excluding results from Urfa. †after excluding results from Mersin. ‡after excluding results from Izmir. §after limiting to 
laboratories using BC analysers. ||after limiting to labs using BC and Sy analysers.
puted as 0.71 and 0.76, respectively (Column 7 of 
Table 3). This indicated a need to derive RIs for Bas 
and Bas% after partition into the three manufac-
turers. In this finding of manufacturer dependency 
of test results for Bas and Bas%, it is notable that 
the between-laboratory difference was more 
prominent for the panel test results (SDRBL1) than 
the volunteers’ results (SDRBL2). We presumed a 
time and temperature dependent instability of ba-
sophils in the blood panel as noted for monocytes. 
For MCHC, RDW, and MPV, we noted apparent bias 
among the 12 laboratories with SDRBL1 of 1.00, 1.28 
and 0.75, respectively. Similar between-laboratory 
differences were also observed in volunteers’ test 
results as indicated by SDRBL2 of 0.66, 0.50, and 
0.68. For MCHC, as shown in Figure 1 - {17}, in the 
laboratories using A and S analyser, the volunteers’ 
results were not consistent despite the use of the 
same analyser. Therefore, we were obliged to de-
rive RIs only for laboratories using BC analysers. 
For RDW, as shown in Figure 2 - {18}, the distribu-
tion of volunteers’ results showed a wide fluctua-
tion among the laboratories using A analysers. 
Therefore, we decided to derive the RI for RDW 
only from the results measured with BC and S ana-
lysers. For MPV, as shown in Figure 1 - {20}, the vol-
unteers’ results were dependent on the analyser. 
This observation was confirmed by the high SDRBM 
(0.67) shown in Column 7 of Table 3. Therefore, we 
decided to derive RIs separately for each manufac-
turer.
Regional differences in reference values
For the remaining parameters which showed no 
analyser dependent bias with SDRBL1 ≤ 0.3, we ex-
amined between-laboratory differences in volun-
teers’ results by computing SDRBL2 as shown in 
Column 6 of Table 3. The following findings were 
obtained.
No obvious between-laboratory difference was 
observed with SDRBL2 ≤ 0.3 for WBC, Neu and 
Neu%, Mon and Mon%, Eos and Eos%, Lym and 
Lym%, MCH, PLT, and Fe. Therefore, RIs were de-
rived after merging the volunteers’ results from all 
12 laboratories. 
Obvious between-laboratory difference with SDR-
BL2 > 0.3 were observed for RBC, Hb, Hct, UIBC, 
TIBC, and ferritin. For ferritin, the high SDRBL2 was 
attributable to an obvious bias in the Izmir results 
(Figure 1 - {22}) despite the fact that the panel test 
results did not show any bias. After exclusion of 
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Figure 2. Comparison of reference intervals derived with or without applying LAVE method
RIs were derived parametrically in two ways with/without LAVE method. Each RI was depicted by the horizontal bar with shades on 
both ends corresponding to the 90% CI derived by the bootstrap method (using iteration of 100 times). The lower and upper limits of 
each RI were determined as the average of the 100 iterations. The LAVE method was applied in order to reduce the influence of latent 
anaemia with the use of the following test items as reference for exclusion: Hb, Hct, MCV, Fe, UIBC, TIBC, and ferritin. One abnormal 
value among them was allowed in the selection process. The data used for derivation of the RIs for MCV and ferritin were those which 
remained after removing biased results from Mersin and Izmir, respectively. For MCHC, derivation of the RIs was applied with the re-
sults from the laboratories using the BC analysers.
the results, SDRBL2 decreased from 0.49 to 0.20 
(Column 6 of Table 3), so we decided to derive the 
RI from all the other laboratory results. For RBC, 
Hb, Hct, UIBC, and TIBC, we regrouped the 12 lab-
oratories into 7 geographical regions, and recom-
puted between-region SDR (SDRBR) as shown in 
Column 7 of Table 3. The SDRBR for RBC, Hb, Hct, 
UIBC, and TIBC were found to be 0.45, 0.39, 0.50, 
0.37 and 0.46. Therefore, the RIs for these parame-
ters were derived for each region as shown in Col-
umn 8 of Table 3. As described below, we pre-
sumed that this regional difference was partly at-
tributable to the altitude of the city where each 
collaborating laboratory was located. 
Multiple regression analysis to assess 
sources-of-variation of test results
MRA was performed for each gender as shown in 
Table 4. By setting standardized partial regression 
coefficients (rp) ≥ 0.20 as a practically significant 
level, an age-related decrease of RVs was noted for 
RBC, Hb, and Hct only in males and an age-related 
increase was noted for RDW in males, and for ferri-
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tin in females. Each volunteer was assigned an alti-
tude corresponding to the city of residence. The 
value of the altitude was set to that of the location 
of the municipal government. An altitude-related 
increase was found for Hb, Hct and ferritin in 
males, and for RBC, Hb, Hct, and TIBC in females. A 
smoking-related increase with rp ≥ 0.2 was ob-
served only for WBC in males. A strong age-related 
increase with rp ≥ 0.394 was observed for ferritin in 
females (Table 4). BMI and alcohol-related changes 
were all well below the critical level of rp ≥ 0.2.
Derivation of reference intervals
The basic scheme for deriving the RI in considera-
tion of analyser dependent bias and regional dif-
ferences in RVs has been described in the previous 
sections. Additional considerations required were 
the need for partition of RVs by gender and age 
subgroups as well as the need for secondary ex-
clusion with the use of the LAVE method to cope 
with latent anomia. 
The calculated RIs and 90% CIs for haematological 
parameters in males and females (M+F), males (M), 
and females (F) are shown in Table 5. For partition 
by gender, we found it necessary for RBC, Hb, Hct, 
Fe, UIBC, and ferritin based on the criteria of SDR-
gender > 0.3 as shown in Table 6. The RIs for these 
parameters were given for M and F separately (Ta-
ble 6). For partition by age subgroup, SDRage > 0.3 
was only noted for ferritin in females as shown in 
Column 5 of Table 3. Therefore, RVs of ferritin were 
partitioned at 45 years of age (Table 6).
To judge the need for the LAVE method, we com-
puted the RIs in two ways with and without apply-
ing it and listed the results in Table 5. The ratio of 
ΔLL to SDBI was well above the critical level of 0.25 
for RBC, Hb, Hct, MCV, MCH and MCHC while the 
ratio of ΔUL to SDBI was above the critical level for 
RDW, UIBC, TIBC and ferritin as shown in Table 5. 
Therefore, for these parameters we judged to use 
RIs with applying the LAVE method. As no appreci-
able changes in the RI limits occurred to other pa-
rameters (WBC, Neu, Neu%, Lym, Lym%, Mon, 
Mon%, Bas, Bas%, PLT and MPV) not primarily re-
lated to the status of latent anaemia (Table 5), for 
these parameters we recommended to use the RIs 
without the LAVE method. Accordingly, the effect 
of the LAVE method was conspicuously observed 
with raised LLs for RBC, Hb, Hct, MCV, MCH and 
MCHC as shown in Figure 2.
Discussion
This nationwide study involving 12 laboratories in 
7 geographical regions of Turkey aimed to estab-
lish well-defined RIs for haematology parameters 
with high precision from a large number of volun-
teers even after partitioning by region, gender, or 
manufacturer, if relevant. Gender was a significant 
factor influencing RVs for Hb, Hct, RBC, ferritin, 
UIBC, and Fe, respectively. With confirmation of no 
analyser-dependent bias and lack of regional dif-
ferences, RIs were derived for nationwide use as 
‘common RIs’ for WBC, Neu, Neu%, Mon, Mon%, 
Lym, Lym%, Eos, Eos%, MCH, MCV, PLT, and Fe. 
‘Manufacturer-specific RIs’ were derived for Bas, 
Bas%, MCHC, RDW and MPV. With the observation 
of regional differences, despite the lack of analys-
er-dependent bias, ‘Region-specific RIs’ were de-
rived for RBC, Hb, Hct, UIBC, and TIBC.
As pre-analytical errors are estimated to account 
for up to 70% of all mistakes made in laboratory 
diagnostics and the standardization of the pre-an-
alytical phase is an important prerequisite of a 
multicentre study (18), all the participating labora-
tories followed the common protocol adopted in 
the IFCC global multicentre study on reference val-
ues and used the same SOPs for harmonizing the 
pre-analytical phase (2). We encouraged the use of 
the same manufacturer and model of tubes for 
standardization. K2EDTA was the preferred antico-
agulant for haematology measurements because 
K3 EDTA can adversely affect some antibodies or 
assays (19). 
The RIs established by a multicentre study are ex-
pected to be in a wider range than those estab-
lished by a single laboratory due to the inclusion 
of between-laboratory variation, which is com-
posed of analytical bias and/or regional bias (8). In 
this study, different haematology analysers from 
different manufacturers were used in the laborato-
ries. Therefore, when between-laboratory differ-
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Table 5. Reference intervals derived with the parametric method for hematological parameters in all subgroups (continued)
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Table 5. Reference intervals derived with the parametric method for hematological parameters in all subgroups (continued)
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Table 5. Reference intervals derived with the parametric method for hematological parameters in all subgroups (continued)
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Test item Unit RIs N SDR- gender
Males + Females Males Females
LL Me UL LL Me UL LL Me UL
WBC 109/L C All 2862 0.11 4.39 7.16 11.59 - - - - - -
Neu 109/L C All 2849 0.00 2.04 4.04 7.54 - - - - - -
Neu% % C All 2863 0.10 0.40 0.57 0.74 - - - - - -
Lym 109/L C All 2863 0.10 1.21 2.28 3.77 - - - - - -
Lym% % C All 2878 0.00 0.17 0.32 0.47 - - - - - -
Mon 109/L C All 2864 0.31 0.26 0.53 0.94 - - - - - -
Mon% % C All 2853 0.23 0.04 0.07 0.12 - - - - - -
Eos 109/L C All 2849 0.25 0.02 0.14 0.50 - - - - - -




0.01 0.06 0.13 - - - - - -
BC 1548 0.01 0.03 0.09 - - - - - -




0.0018 0.0084 0,017 - - - - - -
BC 1552 0.0013 0.0048 0.0101 - - - - - -




- - - 4.43 5.20 6.07 3.96 4.60 5.31
M 139 - - - 4.30 4.99 5.50 4.02 4.52 5.14
MED 288 - - - 4.69 5.36 6.06 3.98 4.68 5.33
BS 391 - - - 4.31 4.99 5.68 3.91 4.38 5.02
A 336 - - - 4.12 4.92 5.78 3.76 4.50 5.22
SEA 410 - - - 4.69 5.52 6.51 4.15 4.82 5.55
CEA 499 - - - 4.55 5.14 5.88 4.06 4.59 5.34




- - - 131 153 175 110 132 152
M 147 - - - 125 147 164 107 131 148
MED 298 - - - 135 156 175 109 131 149
BS 367 - - - 129 150 167 115 130 147
A 352 - - - 119 145 169 102 126 144
SEA 415 - - - 135 157 180 112 133 155
CEA 516 - - - 136 152 170 116 134 154




- - - 0.392 0.456 0.522 0.337 0.398 0.461
M 146 - - - 0.372 0.434 0.482 0.326 0.386 0.438
MED 271 - - - 0.398 0.446 0.505 0.330 0.388 0.440
BS 407 - - - 0.383 0.444 0.498 0.346 0.390 0.439
A 350 - - - 0.360 0.431 0.498 0.310 0.380 0.434
SEA 416 - - - 0.416 0.478 0.548 0.360 0.421 0.485
CEA 514 - - - 0.414 0.457 0.510 0.354 0.405 0.470
EA 398 - - - 0.419 0.473 0.528 0.364 0.411 0.472
Table 6. The list of RIs derived
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MCV* fL C All 2235 0.17 77.2 87.7 95.7 - - - - - -
MCH* pg C All 2383 0.27 25.2 29.3 32.2 - - - - - -
MCHC* g/L MS BC 1283 0.27 319 335 350 - - - - - -
RDW-CV % MS BC+S 1562 0.21 12.2 13.5 16.3 - - - - - -




5.8 8.1 11.9 - - - - - -
BC 1565 7.0 8.8 11.8 - - - - - -
S 325 9.0 10.6 12.7 - - - - - -




- - - 21.5 42 64.7 28.3 49.9 78.1
M 146 - - - 19.0 36.5 59.6 25.4 41.4 63.1
MED 301 - - - 20.9 39.6 64.3 29.9 48.2 82.4
BS 409 - - - 25.5 44.9 64.2 29.9 49.3 68.8
A 347 - - - 24.1 43.8 67.8 29.0 51.4 74.9
SEA 421 - - - 21.8 39.8 55.6 28.4 46.7 68.5
CEA 528 - - - 27.4 44.2 74.8 31.0 51.6 82.7




45.0 58.6 82,2 44.0 58.6 82.2 46.8 63.3 88.9
M 144 42.5 55.4 72.0 42.1 54.8 72.2 42.8 55.7 72.7
MED 298 45.7 60.1 85.0 45.5 58.0 80.7 47.6 62.0 88.6
BS 228 49.2 61.5 78.6 47.1 56.4 72.4 50.3 62.4 79.0
A 318 44.5 61.8 81.3 42.8 59.3 81.2 48.4 63.6 81.8
SEA 421 44.1 58.4 74.3 45.0 56.8 71.3 44.6 60,4 77.4
CEA 522 48.3 63.7 94.4 47.9 61.1 92.8 51.5 65.8 95.5







< 45 y - - - 4.3 17.3 91
≥ 45 y - - - 5.9 38.3 175
RI - reference interval. LL - lower limit of the RI. Me – median. UL - upper limit of the RI. C – common. MS - manufacturer-specific. 
RS - region-specific. SDR - standard deviation ratio. A – Abbott. BC - Beckman Coulter. S - Sysmex. 
*RIs were derived after applying the LAVE method in a mode allowing a single abnormal result in analytes chosen as exclusion 
criteria: HB, HCT, MCV, Fe, UIBC, TIBC and ferritin.
Regions (altitude above sea levels in meters): M - Marmara (100); MED - Mediterranean (295); BS - Black Sea (395); A - Aegean (500); 
SEA - South East Anatolia (745); CEA - Central Anatolia (1000); EA - East Anatolia (745).  
ences in the results were observed, it was not clear 
whether these differences were attributable to re-
gional factors or to analyser-dependent bias, so 
the panel of whole blood samples was prepared 
to detect between-laboratory bias more clearly 
(3). As far as we know, this is the first attempt to 
employ a panel of whole blood samples in a na-
tionwide multicentre study to manage analytical 
bias in determining RIs of haematological parame-
ters.
The test results of the blood panel revealed large 
between-laboratory differences (SDRBL1 > 0.6) in 
values for Bas, Bas%, RDW, MCHC, and MPV, which 
were apparently dependent on the manufacturers 
of the analysers. The between-manufacturer bias 
in test results for MCHC, and MPV have been re-
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ported and attributed to the difference in the as-
say principle (20). 
As a problem of using the blood panel for assess-
ing between-laboratory bias, we found that the 
SDRBL1 tended to be larger than SDRBL2 for Mon, 
Mon%, Bas and Bas%. This appears to be due to 
the instability of those leukocyte sub-fractions 
during transportation and storage. The actual time 
required from sampling (at 8 am) to measurement 
(at a unified time of 11 pm) was 15 hours. The tem-
perature during transportation and storage was 
maintained at 10 − 20°C. This low temperature 
may also have been responsible for the instability 
of the leukocyte sub-fractions (21). Therefore, the 
instability of Mon, Mon%, Bas and Bas% during 
transportation and storage is the limitation of the 
study.
A number of factors may contribute to differences 
between reference intervals reported in different 
studies; these include characteristics of the stud-
ied volunteers, number of studied participants, in-
clusion criteria, the analytical methods and used 
analysers and the manner in which reference in-
tervals were calculated.
Similar to other studies, we found that the RIs of 
RBC, Hb and Hct required partition by gender and 
calculated the RIs of RBC, Hb and Hct separately 
(6,22). Anaemia was defined according to the WHO 
criteria as a haemoglobin concentration lower 
than 120 g/L in females and 130 g/L in males (23). 
The LL for Hb before application of the LAVE meth-
od was 126 g/L in males, and 102 g/L in females, 
but with LAVE the value was 131 g/L in males, and 
110 g/L in females. The LL for males matches with 
the WHO decision limit, but for females, it is lower 
than the decision limit, though appreciably raised 
by the LAVE method with reduced influence of la-
tent anaemia. The LL of Fe was determined as 5.9 
µmol/L for males and 3.5 µmol/L for females. 
These values are comparable to the reported val-
ues for adult Turkish males (7.3 µmol/L) and fe-
males (5.0 µmol/L), but much lower than the val-
ues for males and females (9.2 µmol/L) living in 
Nordic countries (24,25). Iron deficiency usually 
manifests as a falling MCV accompanied by a ris-
ing RDW (26). In the present study, although the LL 
of the RI for MCV in females was raised from 72.9 
to 76.2 fL by the application of the LAVE method 
(in reference to the results of Hb, Hct, Fe, UIBC, 
TIBC, and ferritin), it is still lower than that found in 
the Nordic Reference Interval Project (82 fL) and 
reported in the recent study from Canada (82.5 fL) 
(6,8). However, ferritin values of < 17.8 μg/L have 
been reported to be generally associated with de-
pleted iron stores (23). In the present study, the LL 
of ferritin for males and females was 13.8 μg /L and 
4.7 μg /L, respectively. Taken together, the current 
study showed that many Turkish females have 
mild iron deficiency anaemia.
Many studies have addressed the effect of high al-
titude on Hb, erythropoietin, Hct and PLT (11,27). 
In the present study, judged from the results of 
MRA, the association of the altitude was significant 
for Hb, Hct and ferritin in males and RBC, Hb, Hct, 
and TIBC in females, but not for WBC, WBC sub-
fractions, and PLT. There was a noticeable increase 
in RIs of Hb and Hct with increasing altitude. For 
example, in the Marmara region, which is approxi-
mately 100 m above sea level, the RIs for Hb and 
Hct were 125 - 164 g/L and 0.372 - 0.482 in males, 
respectively, whereas in East Anatolia, which is ap-
proximately 1800 m above sea level and the high-
est region in the study, the RIs for Hb and Hct were 
141 - 178 g/L and 0.419 - 0.528 in males. However, 
the SDRBR computed by ANOVA after sub-group-
ing results from the 12 laboratories into 7 regions 
were appreciably higher in East Anatolia for RBC, 
Hb, Hct, UIBC, and TIBC, with the SDRBR ranging 
from 0.34 to 0.54. These findings indicate a need 
for regional RIs for RBC, Hb, Hct, UIBC, and TIBC in-
stead of common RIs. 
The observed RIs for WBC and sub-fractions of 
WBC in both sexes are in good accordance with 
the values reported in previous studies (6,9,22). Al-
though males had slightly higher values for Mon, 
Mon%, Eos, and Eos%, SDRgender was at or below 
the critical level. Therefore, separate RIs were not 
set by gender for WBC and its sub-fractions. The RI 
derived for eosinophil counts (0.02-0.50x109/L) 
was very similar to the reported RIs for five differ-
ent haematology analysers (20). However, the up-
per reference limit (URL) of the RI for eosinophil 
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count was lower than those reported in Africa (28), 
but higher than those in Canada (6). 
It is well known that cigarette smoking is associat-
ed with elevated levels of some haematological 
parameters (e.g. RBC, Hb, Hct, WBC) (29). The re-
sults of the MRA in this study supported that ciga-
rette smoking was positively associated with the 
value of WBC in males. However, the association 
was not very strong, with rp between 0.20 and 
0.25. Therefore, we did not set different RIs for 
smokers and non-smokers. It has been reported 
that reference values of RBC, Hb and Hct decrease 
with age in males (30). In the present study, age 
was found to be negatively related to the values of 
RBC, Hb and Hct by MRA in males. However, in 
terms of SDRage, the levels of these major parame-
ters were all well below 0.30. Therefore, we did not 
adopt the age-related RIs except for RVs of ferritin 
in females, which showed prominent increase af-
ter the time around menopause.
In conclusion, this nationwide multicentre study 
established well-defined RIs of haematological pa-
rameters for the Turkish population with high pre-
cision from a large number of reference subjects. 
With the novel use of a freshly prepared blood 
panel, we clearly detected analytical bias in values 
for Bas, Bas%, MCHC, RDW and MPV which de-
pended on the manufacturers of haematology an-
alysers, requiring manufacturer-specific RIs for 
those. Regional differences in values of RBC, Hb, 
Hct, and UIBC were observed among the 7 major 
geographical regions of Turkey, which may be at-
tributed to nutritional or environmental factors in-
cluding altitude. 
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